Cm Management, LLC Angion Biomedica Corp. Transaction History

Cm Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$0.48 - $1.02 $32,554 - $69,178	67,822 Added 9.26%	800,000 $464,000
Q4 2022 Feb 09, 2023	BUY	$0.8 - $1.0 $105,742 - $132,178	132,178 Added 22.03%	732,178 $594,000
Q3 2022 Nov 04, 2022	BUY	$0.94 - $1.23 $70,500 - $92,250	75,000 Added 14.29%	600,000 $552,000
Q2 2022 Aug 08, 2022	BUY	$1.1 - $2.23 $82,500 - $167,250	75,000 Added 16.67%	525,000 $599,000
Q1 2022 May 09, 2022	BUY	$1.72 - $2.96 $581,738 - $1 Million	338,220 Added 302.58%	450,000 $954,000

Q4 2021 Feb 02, 2022	BUY	$2.35 - $9.95 $42,370 - $179,398	18,030 Added 19.23%	111,780 $324,000
Q1 2021 May 12, 2021	BUY	$15.01 - $25.74 $1.41 Million - $2.41 Million	93,750 New	93,750 $1.69 Million

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.